SPTX (SPTX) Stock Price & Analysis
SPTX (SPTX) rose 2.35% to USD 24.86 as of September 8, 2026 at 09:09 UTC, according to Nexqual real-time market data.
SPTX last closed at USD 24.86; the session ranged USD 23.63–25 on volume of 104,337 shares. Market capitalization is —, with a 52-week range of USD 14.85–28.38 (NMS). Source: Nexqual, September 8, 2026 at 09:09 UTC.
Key Statistics (as of September 8, 2026 at 09:09 UTC)
| Price | USD 24.86 |
|---|---|
| Change | ▲ 2.35% (up) |
| Previous Close | USD 24.86 |
| Open | USD 24.86 |
| Day Range | USD 23.63 – 25 |
| 52-Week Range | USD 14.85 – 28.38 |
| Volume | 104,337 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SPTX)
Nexqual's technical model rates SPTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 88 daily candles, as of September 8, 2026 at 09:09 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.88 (neutral) |
| vs SMA50 | Above (USD 22.31) |
| MACD | 0.75 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| AVLN | Avalyn Pharma Inc. | USD 37.39 | ▲ 5.09% |
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
| ODTX | Odyssey Therapeutics, Inc. | USD 28.76 | ▲ 8.04% |
| EIKN | Eikon Therapeutics, Inc. | USD 10.86 | ▼ 4.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:09 UTC. This page is informational and not investment advice.